- Report
- August 2024
- 322 Pages
Global
From €3745EUR$4,200USD£3,250GBP
- Report
- July 2025
- 200 Pages
Japan
From €2220EUR$2,490USD£1,927GBP
- Report
- June 2025
- 200 Pages
Japan
From €2220EUR$2,490USD£1,927GBP
- Report
- February 2025
- 80 Pages
India
From €2220EUR$2,490USD£1,927GBP
- Report
- October 2024
- 200 Pages
United States
From €2220EUR$2,490USD£1,927GBP
- Report
- October 2024
- 200 Pages
Europe
From €2220EUR$2,490USD£1,927GBP
- Report
- July 2024
- 190 Pages
Global
From €2220EUR$2,490USD£1,927GBP
From €3121EUR$3,500USD£2,708GBP
- Report
- September 2025
- 85 Pages
India
From €3121EUR$3,500USD£2,708GBP
- Report
- January 2025
- 82 Pages
Vietnam
From €3121EUR$3,500USD£2,708GBP
- Report
- December 2024
- 87 Pages
Spain
From €3121EUR$3,500USD£2,708GBP
- Report
- October 2024
- 82 Pages
India
From €3121EUR$3,500USD£2,708GBP
- Report
- August 2024
- 80 Pages
United States
From €3121EUR$3,500USD£2,708GBP
- Report
- August 2024
- 80 Pages
Spain
From €3121EUR$3,500USD£2,708GBP
- Report
- August 2024
- 82 Pages
Japan
From €3121EUR$3,500USD£2,708GBP
- Report
- August 2024
- 80 Pages
Saudi Arabia
From €3121EUR$3,500USD£2,708GBP
- Report
- July 2024
- 80 Pages
Japan
From €3121EUR$3,500USD£2,708GBP
- Report
- July 2024
- 181 Pages
Global
From €4012EUR$4,500USD£3,482GBP
- Report
- June 2024
- 85 Pages
India
From €3121EUR$3,500USD£2,708GBP
- Report
- May 2024
- 182 Pages
Global
From €4012EUR$4,500USD£3,482GBP

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness.
Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD.
Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more